This paper is in the following e-collection/theme issue:

Surveillance Systems (430) HIV/AIDS/STI Prevention and Care (823) LGBTQ Issues (416) Prevention and Health Promotion (899) Behavioural Surveillance for Public Health (207)

Published on in Vol 8, No 11 (2022): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39053, first published .
A Key Comprehensive System for Biobehavioral Surveillance of Populations Disproportionately Affected by HIV (National HIV Behavioral Surveillance): Cross-sectional Survey Study

A Key Comprehensive System for Biobehavioral Surveillance of Populations Disproportionately Affected by HIV (National HIV Behavioral Surveillance): Cross-sectional Survey Study

A Key Comprehensive System for Biobehavioral Surveillance of Populations Disproportionately Affected by HIV (National HIV Behavioral Surveillance): Cross-sectional Survey Study

Authors of this article:

Dafna Kanny1 Author Orcid Image ;   Dita Broz1 Author Orcid Image ;   Teresa Finlayson1 Author Orcid Image ;   Kathryn Lee1 Author Orcid Image ;   Catlainn Sionean1 Author Orcid Image ;   Cyprian Wejnert1 Author Orcid Image ;   NHBS Study Group2
Article Authors Cited by (8) Tweetations (2) Metrics

Journals

  1. Bigio J, Aho J, Chittle A, Cox J. Improving access to test results for participants in bio-behavioural surveys of people who inject drugs. International Journal of Drug Policy 2023:104192 View
  2. O’Cleirigh C, Foley J, Stanton A, McKetchnie S, Gulbicki L, Muten J, Chai P, Fitch C, Onofrey S, Klevens R, Psaros C. Sexual Networking and HIV/STI Prevention Among Men who have Sex with Men and Identify as Persons of Color in the Era of COVID-19 in Boston, MA: Qualitative Findings from the National HIV Behavioral Surveillance Project. AIDS and Behavior 2024;28(2):473 View
  3. Dumchev K, Kovtun O, Salnikov S, Titar I, Saliuk T. Integrated biobehavioral surveillance among people who inject drugs in Ukraine, 2007-2020. International Journal of Drug Policy 2024:104319 View
  4. Kanny D, Lee K, Olansky E, Robbins T, Trujillo L, Finlayson T, Morris E, Agnew-Brune C, Cha S, Chapin-Bardales J, Wejnert C, Barak N, Brady K, Braunstein S, Davis J, Glick S, Harrington A, Lopez J, Ma Y, Martin A, Mustaafaa G, Nassau T, Olaes G, Reuer J, Rivera A, Robinson W, Sey E, Sicro S, Taylor B, Trujillo D, Wilson E, Wortley P. Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020. MMWR Supplements 2024;73(1):1 View
  5. Chapin-Bardales J, Asher A, Broz D, Teshale E, Mixson-Hayden T, Poe A, Handanagic S, Blanco C, Wejnert C. Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 U.S. cities—National HIV Behavioral Surveillance, 2018. International Journal of Drug Policy 2024:104387 View
  6. Neilan A, Ufio O, Brenner I, Flanagan C, Shebl F, Hyle E, Freedberg K, Ciaranello A, Patel K. Projected Life Expectancy for Adolescents With HIV in the US. JAMA Health Forum 2024;5(5):e240816 View
  7. Eustaquio P, Olansky E, Lee K, Marcus R, Cha S. The Association Between Sexual Violence and Suicidal Ideation Among Transgender Women and the Role of Gender-Affirming Healthcare Providers in Seven Urban Areas in the United States, 2019 to 2020. Journal of Interpersonal Violence 2024 View
  8. Raiford J, DiNenno E, Beer L, Bowman S, Johnson Lyons S, Anderson S, Powell N, Nickson R, Hall G, Neblett Fanfair R. CDC Prioritizes HIV Prevention and Treatment to Reduce HIV Disparities Among Cis-Gender Black Women. Journal of Women's Health 2024 View